Overview

Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Status:
Unknown status
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to analyze gene expression signature and immunohistochemical markers associated with clinical and pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Details
Lead Sponsor:
Barretos Cancer Hospital
Collaborator:
University of Sao Paulo
Treatments:
Albumin-Bound Paclitaxel
Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Paclitaxel